Track topics on Twitter Track topics that are important to you
Concerns of a possible link with myocardial infarction remain, but benefits beat risks, the committee says. Members call for clearer design with the postmarketing study the company proposes.
Medscape Medical News
Original Article: FDA Panel Supports Licensing Two-Dose Hep B VaccineNEXT ARTICLE